Topic Hub
125 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 125 of 125 clinical reviews.
Retatrutide is not yet FDA-approved, so Aetna does not currently cover it. Here is what to expect for prior authorization, formulary placement, step therapy, and appeals once approval occurs.
Read clinical reviewA clinical and coverage guide to Anthem (Elevance Health) retatrutide access, including prior authorization criteria, step therapy requirements, formulary status, and appeal strategies.
Read clinical reviewA clinical and insurance guide to retatrutide coverage under Blue Cross Blue Shield (Federated) plans, including prior authorization criteria, step therapy requirements, formulary status, and how to appeal a denial.
Read clinical reviewA physician-reviewed guide to Cigna coverage for retatrutide: formulary status, prior authorization criteria, step-therapy requirements, denial appeals, and what to do if your claim is rejected.
Read clinical reviewKaiser Permanente does not yet cover retatrutide because the drug remains investigational. Here is what Kaiser members need to know about formulary status, prior authorization, and appeal options once FDA approval occurs.
Read clinical reviewState Medicaid coverage for retatrutide varies widely. Learn which states may cover this investigational triple-agonist, prior authorization criteria, step therapy requirements, and how to appeal a denial.
Read clinical reviewTRICARE does not yet cover retatrutide. Learn why, what the prior-authorization pathway looks like, how to appeal a denial, and what clinical data support a medical-necessity argument.
Read clinical reviewA clinician-reviewed guide to UnitedHealthcare coverage, prior authorization, step therapy, formulary placement, and appeal strategies for retatrutide in 2024 to 2025.
Read clinical reviewCurrent retatrutide pricing in Tennessee, including retail cash-pay costs, insurance and TennCare coverage status, compounded 503A options, telehealth access, and Eli Lilly savings programs.
Read clinical reviewA clinical guide to obtaining retatrutide in Alaska through telehealth providers, 503A compounding pharmacies, and licensed prescribers including MDs, NPs, and PAs.
Read clinical reviewA clinician-reviewed guide to accessing retatrutide in Arizona, including telehealth prescribing, 503A compounding pharmacies, required labs, and what to expect before and after your first injection.
Read clinical reviewA clinical guide to obtaining retatrutide in California through telehealth visits, 503A compounding pharmacies, and prior authorization pathways for Medi-Cal and private insurance.
Read clinical reviewA step-by-step guide to accessing retatrutide in Connecticut, including telehealth options, 503A compounding pharmacies, required labs, prior authorization, and prescriber requirements.
Read clinical reviewA clinical guide to obtaining retatrutide in Delaware through telehealth, 503A compounding pharmacies, and in-person prescribers, including labs, prior authorization, and shipping timelines.
Read clinical reviewA clinical guide to obtaining retatrutide in Washington, DC, covering telehealth prescriptions, 503A compounding pharmacies, required labs, prior authorization, and DC Medicaid coverage for this investigational triple-agonist.
Read clinical reviewA clinical guide to obtaining retatrutide in Georgia through telehealth providers, 503A compounding pharmacies, and licensed prescribers. Covers labs, prior authorization, shipping, and eligibility.
Read clinical reviewA clinical guide to obtaining retatrutide in Idaho through telehealth prescribers, 503A compounding pharmacies, and prior authorization pathways.
Read clinical reviewA clinical guide to obtaining retatrutide in Illinois, including telehealth prescribing, 503A compounding pharmacy access, required labs, insurance coverage, and prescription transfer rules.
Read clinical reviewA clinical guide to obtaining retatrutide in Iowa through telehealth providers, 503A compounding pharmacies, and licensed prescribers including MDs, NPs, and PAs.
Read clinical reviewA clinical guide to obtaining retatrutide in Kansas, covering telehealth prescribing, 503A compounding pharmacies, required labs, prior authorization, and prescription transfer rules.
Read clinical reviewA complete guide to accessing retatrutide in Kentucky through telehealth, licensed prescribers, and 503A compounding pharmacies, with lab requirements, dosing, and cost information.
Read clinical reviewA clinical guide to obtaining retatrutide in Maine, covering telehealth prescribing, 503A compounding pharmacies, required labs, prior authorization, and what to expect during the access process.
Read clinical reviewA clinical guide to obtaining retatrutide in Michigan through telehealth prescribers, 503A compounding pharmacies, and prior authorization pathways for Medicaid coverage.
Read clinical reviewA clinical guide to obtaining retatrutide in Minnesota, including telehealth prescribers, 503A compounding pharmacies, required labs, prior authorization, and step-by-step prescription access.
Read clinical reviewA clinical guide to obtaining retatrutide in Missouri, covering telehealth prescribing, 503A compounding pharmacies, required labs, prior authorization, and cost considerations for this investigational triple-agonist.
Read clinical reviewA clinical guide to obtaining retatrutide in Montana through telehealth providers, 503A compounding pharmacies, and licensed prescribers including MDs, NPs, and PAs.
Read clinical reviewA clinical guide to accessing retatrutide in Nebraska through telehealth, 503A compounding pharmacies, and licensed prescribers. Covers labs, prior authorization, and shipping.
Read clinical reviewA clinical guide to accessing retatrutide in Nevada through telehealth providers and 503A compounding pharmacies, including required labs, prescriber qualifications, and current regulatory status.
Read clinical reviewA clinical guide to obtaining retatrutide in New Hampshire via telehealth, 503A compounding pharmacies, and in-person prescribers. Covers labs, eligibility, prior authorization, and shipping timelines.
Read clinical reviewA complete guide to obtaining retatrutide in New Mexico through telehealth providers, licensed prescribers, and 503A compounding pharmacies, including labs, prior authorization, and shipping timelines.
Read clinical reviewA clinician-reviewed guide to obtaining retatrutide in New York State, covering telehealth prescribing, 503A compounding pharmacies, lab requirements, prior authorization, and expected timelines.
Read clinical reviewA complete guide to obtaining retatrutide in North Carolina, covering telehealth prescribers, 503A compounding pharmacies, required labs, insurance coverage, and dosing protocols for NC patients.
Read clinical reviewA clinical guide to accessing retatrutide in North Dakota, including telehealth options, 503A compounding, required labs, prescriber types, and current regulatory status of this investigational triple-agonist.
Read clinical reviewA clinical guide to obtaining retatrutide in Oregon, including telehealth prescribing, 503A compounding pharmacies, required labs, prior authorization, and cost-saving strategies.
Read clinical reviewA clinical guide to obtaining retatrutide in Pennsylvania through telehealth providers, 503A compounding pharmacies, and licensed prescribers including required labs, prior authorization, and shipping timelines.
Read clinical reviewA clinical guide to obtaining retatrutide in Rhode Island, covering telehealth prescribing, 503A compounding pharmacies, required labs, prior authorization, and expected timelines.
Read clinical reviewA clinical guide to obtaining retatrutide in South Carolina, including telehealth options, 503A compounding pharmacies, required labs, prescriber types, and prior authorization steps.
Read clinical reviewA step-by-step clinical guide to accessing retatrutide in South Dakota via telehealth, compounding pharmacies, and in-person prescribers. Includes labs, dosing, costs, and legal status.
Read clinical reviewA clinical guide to obtaining retatrutide in Tennessee through telehealth, 503A compounding pharmacies, and licensed prescribers, including labs, prior authorization, and shipping details.
Read clinical reviewA clinical guide to obtaining retatrutide in Utah through telehealth providers, 503A compounding pharmacies, and licensed prescribers including MDs, NPs, and PAs.
Read clinical reviewA clinical guide to obtaining retatrutide in Virginia through telehealth providers, 503A compounding pharmacies, and licensed prescribers. Covers labs, prior authorization, and shipping timelines.
Read clinical reviewComplete guide to obtaining retatrutide in Washington state via telehealth, 503A compounding pharmacies, and licensed prescribers including required labs and prior authorization steps.
Read clinical reviewA clinical guide to obtaining retatrutide in Wisconsin through telehealth providers, 503A compounding pharmacies, and in-person prescribers. Covers labs, prior authorization, dosing, and state-specific access details.
Read clinical reviewA clinical guide to obtaining retatrutide in Wyoming through telehealth prescribers and 503A compounding pharmacies, including lab requirements, prior authorization, and shipping timelines.
Read clinical reviewEvidence-based guidance on stopping retatrutide safely, including taper strategies informed by incretin-class discontinuation data, weight-regain timelines, and metabolic monitoring.
Read clinical reviewA clinical overview of retatrutide dosing in adolescents aged 12 to 17, covering trial evidence, dose-escalation schedules, safety monitoring, and how pediatric use differs from adult protocols.
Read clinical reviewEvidence-based monitoring guide for retatrutide use in adolescents aged 12 to 17, covering growth tracking, metabolic labs, mental health screening, and safety parameters during investigational GLP-1/GIP/glucagon triple-agonist therapy.
Read clinical reviewA clinical review of retatrutide safety considerations for adolescents aged 12 to 17, covering trial data, growth concerns, mental-health monitoring, and what parents and prescribers need to know.
Read clinical reviewA clinician-reviewed guide to retatrutide dosing for adults aged 30 to 49, covering the titration schedule, trial evidence from Jastreboff et al. 2023, and what investigational status means for patients today.
Read clinical reviewA clinician-reviewed guide to monitoring retatrutide in adults aged 30 to 49, covering metabolic labs, cardiovascular checks, GI tolerance, injection-site assessment, and schedule recommendations based on Phase 2 trial data.
Read clinical reviewA complete guide to retatrutide pricing in Alabama for 2026, covering cash-pay costs, Alabama Medicaid status, compounded 503A options, telehealth access, and insurance coverage strategies.
Read clinical reviewCurrent retatrutide pricing in Arizona for 2026, including brand-name projected costs, compounded options via 503A pharmacies, insurance coverage status, and savings programs.
Read clinical reviewCurrent retatrutide pricing in Arkansas for 2026, including cash-pay retail rates, compounded 503A pharmacy options, Medicaid coverage status, and telehealth access. Reviewed by the HealthRX medical team.
Read clinical reviewCurrent retatrutide pricing in California for 2026, including insurance coverage, Medi-Cal access, compounded options, telehealth availability, and manufacturer savings programs.
Read clinical reviewWhat retatrutide costs in Colorado in 2026, including retail pricing, compounded alternatives, Medicaid coverage status, insurance options, and the Eli Lilly savings card.
Read clinical reviewWhat retatrutide costs in Connecticut in 2026, including list price, compounded pricing via 503A pharmacies, Medicaid and private insurance coverage, telehealth access, and discount programs.
Read clinical reviewA physician-reviewed breakdown of retatrutide cost in Georgia for 2026, covering cash-pay prices, Georgia Medicaid coverage, 503A compounded options, telehealth access, and insurance reimbursement pathways.
Read clinical reviewWhat retatrutide costs in Hawaii in 2026, including expected retail pricing, Hawaii Medicaid coverage status, compounded retatrutide legality, telehealth access, and savings programs.
Read clinical reviewCurrent retatrutide pricing for Idaho residents in 2026, including insurance coverage, Medicaid status, compounded options through 503A pharmacies, and telehealth availability.
Read clinical reviewCurrent retatrutide pricing in Illinois, including projected retail costs, Illinois Medicaid coverage with prior authorization, compounded options via 503A pharmacies, and manufacturer savings programs.
Read clinical reviewShowing the first 60 matches. Use search or filters to narrow the library.